Equities

Uscom Ltd

UCM:ASX

Uscom Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.039
  • Today's Change-0.006 / -13.33%
  • Shares traded15.74k
  • 1 Year change--
  • Beta-0.9829
Data delayed at least 20 minutes, as of Nov 17 2024 23:49 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Uscom Limited is a medical technology company. It specializes in the development and marketing of non-invasive cardiovascular and pulmonary medical devices. It has three suites of devices in the field of cardiac, vascular, and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities, and is used to guide treatment. The USCOM 1A device has applications in emergency, intensive care medicine and anesthesia. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms in the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. Its VENTITEST digital ultrasonic ventilator testing solution is a new system for testing ventilators.

  • Revenue in AUD (TTM)3.77m
  • Net income in AUD-2.07m
  • Incorporated1999
  • Employees11.00
  • Location
    Uscom LtdL 8 66 Clarence StreetSYDNEY 2000AustraliaAUS
  • Phone+61 29247-4144
  • Fax+61 29247-8157
  • Websitehttps://www.uscom.com.au/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Adherium Ltd2.29m-10.22m7.59m----1.13--3.31-0.0275-0.02750.00620.00890.20311.051.22---90.61-110.82-129.82-157.5635.3349.25-446.19-413.922.43--0.0142---54.47-4.27-3.71---83.48--
Visioneering Technologies Inc13.39m-5.39m7.71m----1.14--0.5755-0.122-0.1220.2950.12241.212.087.06---48.75-76.38-75.48-97.7056.7444.90-40.22-98.702.44--0.00--19.0121.3641.05------
Inhalerx Ltd891.64k-756.82k8.02m--------9.00-0.004-0.0040.0047-0.00031.05--2.81---88.94-80.34-252.07-99.88-----84.88-500.13---11.571.19--2,226.0922.7925.10------
Global Health Limited8.67m-1.31m8.13m49.00------0.9377-0.0226-0.02260.1493-0.052.80--11.81---42.35-34.67---112.4181.1878.53-15.14-32.95---12.78----10.869.4283.71---55.12--
Memphasys Ltd60.00k-4.44m8.82m24.00--1.01--146.92-0.004-0.0040.000050.0050.00440.3952-----32.78-19.51-54.58-25.222.67---7,403.38-12,238.500.2767-13.900.4104--290.37---30.55---21.39--
Uscom Ltd3.77m-2.07m11.27m11.00--3.60--2.99-0.0118-0.01180.02140.01250.73160.887411.28---40.23-30.60-53.05-36.9783.8086.20-54.99-53.502.54-17.760.2443--38.730.997719.92---12.44--
Atomo Diagnostics Ltd4.24m-6.85m13.42m----1.33--3.17-0.0108-0.01080.00670.01580.30441.253.09---49.17-31.42-54.41-34.2041.4842.58-161.56-120.994.84--0.0083--66.6351.0131.23---54.38--
Control Bionics Ltd5.97m-5.91m16.34m----2.10--2.74-0.0381-0.03810.03740.03150.67322.412.98---66.73-41.07-85.40-45.9775.6268.78-99.13-92.331.40-112.620.133--2.0846.24-5.02--67.72--
Data as of Nov 17 2024. Currency figures normalised to Uscom Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.